Inhibitex, Inc. (INHX)

[mlkrborn]

Inhibitex drops 29% after Pharmasset amends hepatitis C trial
Theflyonthewall.comTheflyonthewall.com – 2 hours 15 minutes ago


Companies:

* Inhibitex, Inc.
* Pharmasset, Inc.
* Idenix Pharmaceuticals Inc.

RELATED QUOTES
Symbol Price Change
INHX 9.60 -3.39
VRUS 125.29 -2.50
IDIX 7.01 -0.76
ACHN 7.47 +0.09

Companies developing hepatitis C virus treatments such as Inhibitex (INHX), Idenix (IDIX) and Achillion (ACHN) are moving lower after Pharmasset (VRUS) said it will amend the design of its QUANTUM Phase 2b trial. Pharmasset announced that it detected laboratory abnormalities associated with liver function in subjects receiving PSI-938 300 mg once daily.